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defect is likely associated with a new form of ciliopathy phenotype; additional patients may further validate this association.
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| INTRODUCTION
The primary cilium is a solitary microtubule-based structure displayed on the surface of a diverse array of cells in embryonic and adult tissues (Goetz & Anderson, 2010) . Primary ciliogenesis, the dynamic process of assembling the primary cilium, occurs in interphase when a mother centriole is differentiated to form the basal body (Ishikawa & Marshall, 2011) . The basal body supplies essential components for primary cilium assembly and elongation via the intraflagellar transport machinery (Taschner & Lorentzen, 2016) . Actin cytoskeleton dynamics plays a key role in ciliogenesis; the assembly of contractile actin filaments represses ciliogenesis. Similarly, nucleating factors which promote actin polymerization repress primary cilium assembly and elongation. In contrast, actin depolymerization activates ciliogenesis by stabilizing the pericentrosomal preciliary compartment, a vesiculotubular structure that contributes to ciliogenesis, and by inhibiting transcription factors from the Hippo pathway, which induce the expression of cilium disassembly factors (Bershteyn, Atwood, Woo, Li, & Oro, 2010; Cao et al., 2012; Kim et al., 2010 Kim et al., , 2015 .
In the last 15 years the primary cilium has emerged as a key organelle in numerous physiological and developmental processes. This non-motile structure acts as a cell signaling center, contributing to normal development through the regulation of major signaling pathways, for example, Hedgehog and PDGF (reviewed in Goetz & Anderson, 2010) . Genetic defects in primary cilia formation, maintenance, or function underlie a wide array of ciliopathies in human including craniofacial, brain and heart malformations, and retinal and hearing defects (Guemez-Gamboa, Coufal, & Gleeson, 2014; MaySimera & Kelley, 2012; Tian et al., 2017; Willaredt, Gorgas, Gardner, & Tucker, 2012; Yildiz & Khanna, 2012) .
We now report a novel ciliopathy phenotype, associated with CDK10 mutation, which affects multiple organ systems, including the brain, inner ear, retina, and heart.
| PATIENT
The subject of this study was an 11 year-old female, the second child to non-consanguineous healthy parents of Ashkenazi-Jewish ancestry.
Pregnancy was complicated by intra-uterine growth retardation; agenesis of corpus callosum was noted on ultrasound examination at 32 weeks of gestation. The patient was delivered at 39 weeks of gestation with a birth weight of 1480 g (−3.7 S.D.) and head circumference of 30.5 cm (−3.0 S.D.). Shortly after birth, heart failure due to a patent ductus arteriosus became apparent, necessitating surgical intervention at 8 months of age. In the aftermath of the surgery, vocal cord paralysis was noted and a tracheostomy was performed. A gastro-jejunostomy was placed at 8 months due to vomiting and failure to thrive. From the age of 2 years, growth hormone treatment was initiated with a favorable response. During the second year of life, global developmental delay became apparent but developmental regression was never noted. Physical examination at that time revealed facial dysmorphism which consisted of high forehead, mild bilateral ptosis, upslanting palpebral fissures, telecanthus, broad nasal bridge, and long philtrum ( Figure 1a ). Of note, no ano-genital malformations were noted. Further investigations revealed bilateral sensorineural deafness and retinitis pigmentosa with high myopia. Vision in adequate lighting was relatively preserved with glasses and there was no progression of the retinopathy over time. At the time of writing, age 11 years, weight was 31.3 kg and height was 131 cm (15th and 5th percentile, respectively). Head circumference was 50 cm. The patient lacked expressive language but had language understanding that enabled her to follow simple commands. Her cognitive development was consistent with severe intellectual disability, extreme hyperactivity, and inattentive behavior. She was ambulant with an unstable broad-based gait; the neurological examination was noted for prominent weakness though creatine kinase level, muscle histology, and the enzymatic activity of the five mitochondrial respiratory chain complexes were normal.
Routine laboratory investigations as well as metabolic work-up including plasma amino acids, acylcarnitines, very-long-chain fatty acids, isoelectric focusing of transferrin, lactate and ammonia, and urine organic acids, were all within the normal range. Brain MRI at 6 years of age disclosed a rudimentary corpus callosum and paucity of white matter with attendant lateral ventricular widening ( Figures   1c and 1d) . MRI of the spine, performed because of the dysmorphism, disclosed dys-segmentation of C3-C4 and a rudimentary coccyx with adjacent dermal sinus. Of note abdominal ultrasound including kidneys size and shape was normal. Exhaled NO testing was normal as was electron microscopic examination of the nasal cilia. | 93 using default parameters with the human genome assembly hg19 (GRCh37) as reference. Parental consent was given for genetic studies.
The study was performed with the approval of the ethical committees of Hadassah Medical Center and the Israeli Ministry of Health.
| Fibroblasts cell culture and non-sense mediated decay (NMD) pathway inhibition
Primary skin fibroblasts were grown until confluence in RPMI 1640 medium with 20% fetal bovine serum (Sigma-Aldrich, St. Louis, MO) and 1% penicillin/streptomycin. The cells were treated with 100 μg/ml Cycloheximide (EMD Millipore, St. Louis, MO) for 6 hr before RNA extraction to inhibit NMD, or they were serum starved for 24 hr, to induce ciliogenesis, before immunofluorescence experiments.
| Immunofluorescence and image analysis
Cells were either fixed in 4% paraformaldehyde for 10 min and permeabilized with 0.3% Triton X100 for 15 min, or fixed and permeabilized with cold methanol for 10 min, and blocked with donkey Chr.17:48699055 C>A, rs201565895, p.T1987 K in the CACNA1G gene). We focused on the homozygous variant c.870_871del in CDK10 which resides in exon 11 of the 13 coding exons, because of its deleterious nature and because the MAF of the other homozygous variants was relatively high. Importantly, CDK10 is the binding partner of CycM, which is encoded by FAM58A (Guen et al., 2013) . FAM58A is mutated in patients with STAR syndrome who present with facial dysmorphism reminiscent of that of our patient (Figure 1a,b) .
The CDK10 c.870_871del variant is carried by 36 of the ∼141,000 healthy individuals whose exome and genome analyses are deposited at gnomAD website (Lek et al., 2016) ; nearly all of the carriers for this variant are of Ashkenazi-Jewish descent, accounting for a carrier rate of 1/290 in this community. Importantly, no homozygous LOF variants in this gene are present in the entire gnomAD cohort (Lek et al., 2016) .
Sanger sequencing confirmed segregation of the c.870_871del variant with the disease in the family (Figure 2a) . To examine the consequences of the variant at the RNA level, we studied CDK10 mRNA abundance and noted slightly increased level in the patient compared to the control cells (Figure 2b) . Importantly, the CDK10 mRNA level remained unchanged when the patient cells were incubated with cycloheximide (Carter et al., 1995) , in contrast to the PTBP1 mRNAs, which serves as a control because it is known to be subjected to non-sense mediated decay (NMD). This result indicates that the CDK10 mutant RNA is not degraded by the NMD pathway (Figure 2c ).
Our recent work showing that the CDK10/ Cyclin M (CycM) protein kinase regulates ciliogenesis and primary cilium elongation (Guen et al., 2016) prompted us to examine primary cilia on the patient fibroblasts.
Twenty four hour after plating, at low confluence, a morphological difference could be observed between the patient and control fibroblasts with the patient cells appearing less elongated than the control cells, suggesting that the CDK10 mutation affects the cytoskeleton (Figure 3a) .
When the cells reached confluence, this morphological difference appeared even more striking and the patient cells were more densely populated than the control cells (not shown). We then starved the cells for 24 hr to induce ciliogenesis, and observed primary cilia and centrosomes via acetylated-tubulin and γ-tubulin staining, respectively. Whereas control cells exhibited normal primary cilia protruding from centrosomes, the patient cells exhibited absent or shorter cilia and weaker γ-tubulin staining (Figure 3b ). To confirm these observations, we stained the cells for Arl13b, another marker of primary cilia, observing again fewer and shorter cilia on patient cells as compared to the control cells (Figure 3c-e) .
| DISCUSSION
The patient report herein suffered from growth retardation, global developmental delay with absent speech acquisition, agenesis of corpus callosum and paucity of white matter, sensorineural deafness, retinitis pigmentosa, vertebral anomalies, patent ductus arteriosus, and facial dysmorphism. The facial dysmorphism consisted of high forehead, upslanting palpebral fissures, telecanthus, broad nasal bridge, and long philtrum. As mentioned above, CDK10, one of the identified mutated gene, is the binding partner of CycM (Guen et al., 2013) , the protein mutated in patients with STAR syndrome. These patients present with facial dysmorphism which bears similarity to that of our patient (Figure 1a,b) , syndactyly, ano-urogenital malformations, short stature, and variable heart and eye abnormalities; the syndrome is transmitted in an X-linked dominant manner (Unger et al., 2008; Zarate, Farrell, Alfaro, & Elhassan, 2015) .
CDK10 and CycM form a heterodimeric protein kinase; silencing each one of them phenocopies silencing the other (Guen et al., 2013) . We have previously shown that CDK10/CycM is a repressor of ciliogenesis via its
role in the promotion of actin network formation through phosphorylation of PKN2 and promotion of RhoA signaling. CDK10/CycM is localized to the base of primary cilia, concentrated at the mother centriole (Guen et al., 2016) . In quiescent immortalized retinal pigmented epithelial (RPE) cells, knocking down CDK10 or CycM resulted in significant increase in the number of ciliated cells, abnormally long cilia and promotion of the maintenance of primary cilia upon cell cycle re-entry (Guen et al., 2016) .
The actin network was disrupted and actin stress fibers were lost in the absence of CDK10 or CycM. Extensive screen for CDK10/CycM phosphorylation substrates identified several proteins, all known regulators of actin dynamics. Knocking down PKN2, (which is one of these regulators), or simply abolishing PKN2 aminoacids that are phosphorylated by CDK10/CycM, mimicked CDK10 or CycM deficiency, with a decrease of actin stress fibers, and an increase in both ciliogenesis and in cilia length. Concomitantly, PKN2 deficiency resulted in a destabilization of the GTPase RhoA, a protein that can repress ciliogenesis.
These findings and the observation that kidney sections from a STAR patient display dilated renal tubules and elongated cilia, led us to propose that STAR syndrome, which is associated with mutations in the CycM gene, is a ciliopathy (Guen et al., 2016) .
The present report underscores the importance of CDK10 for normal regulation of ciliogenesis; the homozygous c.870_871del variant in the CDK10 gene is likely associated with severe developmental defects and abnormal primary cilia. However, in contrast to the increased ciliogenesis with abnormally long cilia observed in STAR patients with CycM loss-of-function mutations or in the experimental CDK10/CycM knockdown, the homozygous CDK10 c.870_871del variant results in shorter, less abundant cilia. We therefore examined CDK10 mRNA abundance in the patient and control cells and noted that the mutant CDK10 mRNA is slightly more abundant than WT mRNA, indicating perhaps a negative feedback regulation of the expression of the wild-type gene. Furthermore the mutant mRNA is not degraded by the NMD pathway; this result suggests that instead of the WT 360 amino acids long CDK10 protein, a shorter, 307 residues long isoform is produced, containing missense 17 amino acids at its C-terminus. If expressed, this mutant would be devoid of the C-terminal bipartite nuclear localization sequence, while potentially retaining its ability to interact with CycM, two features that may phenocopy the naturally-occurring shorter CDK10 isoforms produced from the highly complex alternative splicing events concerning the CDK10 gene (Sergère, Thuret, Le Roux, Carosella, & Leteurtre, 2000) . As observed in a number of proteins playing multiple, complex regulatory roles, the different WT CDK10 isoforms are suspected to exert distinct, perhaps partly opposing functions (Guen, Gamble, Lees, & Colas, 2017) . We therefore speculate that the shorter is conceivable that this mutated polypeptide is counterbalanced by WT isoforms and would only produce effects in a homozygous context. Thus, CDK10 defect is likely associated with a new form of ciliopathy phenotype, bearing clinical similarity to CycM defect only in the facial appearance of the patients, and sharing the retinal involvement, the hearing loss and the short stature with many patients with ciliopathies including Senior-Løken syndrome, Bardet-Biedl syndrome and Alström syndrome, and the corpus callosum agenesis with patients suffering from KIF7 and OFD1 ciliopathies (Barakeh et al., 2015; Del Giudice et al., 2014) . Still, additional, unrelated patients will be needed to prove the association between this phenotype and CDK10 mutation, but until that occurs, the present report provides compelling evidence, worthy of publication. 
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